Delivery Order SPE2DR25D1103-SPE2DR26FE574
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $3,354.98. This firm fixed-price delivery order, with an ultimate completion date of November 18, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Jardiance 25 mg tablets (90-count units) at a ceiling value of $1,042.02. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 11, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) valued at $64,915.53. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a Department of Defense component responsible for supplying medical and pharmaceutical products to military and federal healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (30-count units) on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed price, non-set-aside delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The award represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 22, 2025, by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets (90-count packages). This non-set-aside, competitively awarded delivery order carries a firm fixed price ceiling value of $23,196.13 and is scheduled for ultimate completion on December 23, 2025. The award represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,781.83 delivery order on December 1, 2025, for 90-count tablets of Jardiance 10 mg, a diabetes management medication. The contract is non-competitive and represents a firm fixed-price delivery order with performance through December 2, 2025, to be fulfilled at the company's Conshohocken, Pennsylvania facility. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $13,245.31. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded, non-set-aside contract. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $46,487.79. This is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $5,122.35. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract action against AmerisourceBergen Drug...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE574Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) valued at $7,269.84 with firm fixed pricing. This non-set-aside delivery order is scheduled for completion by December 31, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare programs worldwide. This delivery order for Jardiance, a diabetes medication, exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains through competitively awarded federal contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 12/29/25 |